Clinical trialNCT06311214RecruitingPhase 2Interventional

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

SponsorNational Cancer Institute (NCI)Enrollment500Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center LAO
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Comprehensive Cancer Center
Duarte, California, United States
Alex Chehrazi-Raffle
Recruiting
Uc San Diego Health System - Encinitas
Encinitas, California, United States
Sharon Choi
Recruiting
City of Hope at Irvine Lennar
Irvine, California, United States
Alex Chehrazi-Raffle
Recruiting
Uc San Diego Moores Cancer Center
La Jolla, California, United States
Sharon Choi
Recruiting
Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
Sharon Choi
Recruiting
Yale University
New Haven, Connecticut, United States
So Yeon Kim
Recruiting
Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
So Yeon Kim
Recruiting
Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
Thomas J. George
Recruiting
Northwestern University
Chicago, Illinois, United States
Pedro Viveiros
Recruiting
University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
Susanne M. Arnold
Recruiting
Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
Daniel Johnson
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Kartik Sehgal
Recruiting
Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
Andrew Davis
Recruiting
Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
Andrew Davis
Recruiting
Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
Andrew Davis
Recruiting
Siteman Cancer Center-South County
St Louis, Missouri, United States
Andrew Davis
Recruiting
Washington University School of Medicine
St Louis, Missouri, United States
Andrew Davis
Recruiting
Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
Alexander Wei
Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
David A. Liebner
Recruiting
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Christina Washington
Recruiting
Vanderbilt Breast Center at One Hundred Oaks
Nashville, Tennessee, United States
Vicki L. Keedy
Recruiting
Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
Vicki L. Keedy
Recruiting
Ut Md Anderson Cancer Center
Houston, Texas, United States
Funda Meric-Bernstam
Recruiting
University of Virginia Cancer Center
Charlottesville, Virginia, United States
Matthew J. Reilley
Recruiting
Vcu Massey Comprehensive Cancer Center
Richmond, Virginia, United States
Andrew Poklepovic
Recruiting
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
Madison, Wisconsin, United States
Cheryl M. Czerlanis
Recruiting
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Cheryl M. Czerlanis
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Mar 2025
Primary completion: 31 Mar 2028
Completion: 31 Mar 2028
Last update posted: 17 Jun 2026
Registered enrollment: 500
Registry id: NCT06311214

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.